drugset / Trial / NCT04368663

The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

NCT04368663 ↗

Recruiting 100 enrolled Showa Inan General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.

Timeline

Start
2020-05-01
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactomin Unknown 3 g —
Subject TJ-134 Unknown 7.5 g —